Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-25 | 2024-12-25 | 2024-12-25 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.9B | $2.5B | $2.5B | $2.7B | $3.1B | |
| Total Assets | $8.8B | $8.1B | $8.5B | $8.8B | $10.7B | |
| Current Liabilities | $1.3B | $1.3B | $1.3B | $2B | $1.8B | |
| Total Liabilities | $3.7B | $3.5B | $3.6B | $4B | $4.8B | |
| Total Equity | $5.1B | $4.6B | $4.8B | $4.8B | $6B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-25 | 2024-12-25 | 2024-12-25 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
Chocoladefabriken Lindt & Sprüngli AG is a holding company, which engages in the manufacture and sales of chocolate products. It operates through the following segments: Europe, North America, and Rest of the World. The Europe segment focuses on European companies and business units including Russia. The North America segment includes companies in the USA, Canada, and Mexico. The Rest of the World segment operates in Australia, Japan, South Africa, Hong Kong, China, and Brazil as well as the business unit's distributors and global travel retail. The company was founded by Rudolf Sprüngli-Ammann and David Sprüngli-Schwarz in 1845 and is headquartered in Kilchberg, Switzerland.
In the current month, CHLSY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CHLSY average analyst price target in the past 3 months is --.
According to analysts, the consensus estimate is that Chocoladefabriken Lindt & Sprüngli AG share price will drop to -- per share over the next 12 months.
Analysts are divided on their view about Chocoladefabriken Lindt & Sprüngli AG share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Chocoladefabriken Lindt & Sprüngli AG is a Sell and believe this share price will rise from its current level to --.
The price target for Chocoladefabriken Lindt & Sprüngli AG over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Chocoladefabriken Lindt & Sprüngli AG is a --. 0 of 0 analysts rate the stock a -- at this time.
You can purchase shares of Chocoladefabriken Lindt & Sprüngli AG via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Chocoladefabriken Lindt & Sprüngli AG shares.
Chocoladefabriken Lindt & Sprüngli AG was last trading at $14.80 per share. This represents the most recent stock quote for Chocoladefabriken Lindt & Sprüngli AG. Yesterday, Chocoladefabriken Lindt & Sprüngli AG closed at $14.80 per share.
In order to purchase Chocoladefabriken Lindt & Sprüngli AG stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.